CVS Health Corporation is listed among the 15 Dividend Stocks that Outperform the S&P 500. Wells Fargo analyst adjusted the price target for CVS to $102 from $103, noting solid Q3 results but a moderated 2025 outlook due to a steeper Part D medical loss ratio.

Despite recent challenges, CVS is adapting to industry demands with online ordering and same-day delivery services. The company is committed to cost reductions and has expanded its primary care operations through acquisitions like Oak Street Health in 2023.

CVS continues to diversify its healthcare business, with initiatives like the Cordavis partnership to reduce drug costs and improve accessibility. The company’s varied healthcare services support its position as a leading player in the sector.

As a diversified healthcare company, CVS operates as both a healthcare provider and a pharmacy benefit manager. While it offers investment potential, some AI stocks may offer greater upside with less downside risk.

For more investment opportunities, check out 15 High Quality Dividend Stocks for Long-Term Investors and 14 Best Up and Coming Dividend Stocks to Buy. No disclosures.

Read more at Yahoo Finance: Wells Fargo Notes Solid Q3 Results for CVS but Moderates 2025 Bull Case for HCB Segment